- Home
- KYN vs OLMA Comparison
KYN vs OLMA Comparison
Compare KYN & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KYN | OLMA |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | KYN | OLMA |
|---|---|---|
| Price | $14.35 | $13.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $44.89 |
| AVG Volume (30 Days) | 344.2K | ★ 1.6M |
| Earning Date | 01-01-0001 | 03-16-2026 |
| Dividend Yield | ★ 8.99% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $347.47 |
| P/E Ratio | $20.18 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.82 | $2.86 |
| 52 Week High | $14.49 | $36.26 |
Technical Indicators
Market Signals| Indicator | KYN | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 64.56 | 27.43 |
| Support Level | $12.09 | $4.15 |
| Resistance Level | $14.45 | $27.38 |
| Average True Range (ATR) | 0.25 | 1.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 79.86 | 16.67 |
Price Performance
Historical ComparisonAbout KYN Kayne Anderson Energy Infrastructure Fund Inc.
Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.